Compare · 3 funds side by side · dividends reinvested

ARKG, XLV and VOO

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$17,749VOO · best of the three

02 / 04

ARKG, XLV and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.07%+11.5%+11.9%+24.1%+12.2%−8.9%12.7%$1.00T1.8

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.39%+20.4%+29.7%+16.2%+8.5%−10.5%16.4%$49.1B2.0

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B2.3

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: ARKG 2014 · XLV 1998 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

ARK Genomic Revolution ETF · $2.2B$6,586

ARKG

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,068

$10,000 five years ago, dividends reinvested · they hold 5.2% in common

ARKGMeasureXLV

+70.9%Year to dateJan 1 → Nov 3+20.4%

+59.0%1 yearTotal return+29.7%

+30.6%3 years · per year$10,000 became $22,262 · $15,709+16.2%

−8.0%5 years · per year$10,000 became $6,586 · $15,068+8.5%

0.75%Expense ratio$75 · $8 a year on $10k · lower is better0.08%

0.00%Trailing 12-mo yield$0 · $139 a year on $10k1.39%

−27.5%Worst dropSmaller is better−10.5%

45.8%VolatilityLower is calmer16.4%

ARKGXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5XLV wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

ARKG vs XLV: Top 5 Holdings

Today

ARKG

35.4%in top 5

XLV

in top 545.0%

ARKGStockXLV

not top 5LLY16.5%

not top 5JNJ9.9%

9.8%TEMnot top 5

not top 5ABBV7.7%

7.5%TXGnot top 5

7.4%TWSTnot top 5

not top 5UNH5.5%

5.5%CRSPnot top 5

not top 5MRK5.4%

5.1%GHnot top 5

Held in common5.2%

End-of-day Nov 3, 2026 · share of each fund

ARKG vs XLV Returns, Every Period

ARKARKG

−8.0%

5 years, per year

XLVSPDR

+8.5%

5 years, per year

ARKGXLVFaded: behind in that period

3–1ARKG wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

ARKG vs XLV

YTD

ARKARKG

+70.9%

XLVSPDR

+20.4%

+70.9%Year to date+20.4%

−27.5%Worst drop · 1Y−10.5%

45.8%Volatility · 1Y16.4%

0.0%Yield1.4%

$2.2BAssets$49.1B

3–1XLV wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: ARKG, XLV, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

XLV0.08%$8

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: ARKG, XLV, VOO

1.39%highest, XLV

FundTrailing yieldYield$10k

XLV1.39%$139

VOO1.07%$107

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$131most kept, XLV

XLV$139 − $8 = $131

VOO$107 − $3 = $104

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: ARKG, XLV, VOO

Today

9.3%most shared, XLV and VOO

ARKGXLVVOO

ARKG—5.2%1.5%

XLV5.2%—9.3%

VOO1.5%9.3%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+59.0%ARKG, at 45.8% volatility

VOOWorst drop−8.9%12.7% vol

XLVWorst drop−10.5%16.4% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XLVARKG

+20.4%Year to date+70.9%

1.4%Yield0.0%

+29.7%Past year+59.0%

0.08%Fee0.75%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026

VOO vs IVV

YTD

VanguardVOO

+11.5%

IVViShares

+11.6%

+11.5%Year to date+11.6%

1.1%Yield1.1%

$1.00TAssets$872B

1–0IVV wins

End-of-day Nov 3, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026